medicinal
How Celebrities & Politicians Help Build Cannabis Brands
There’s no doubt that celebrities can have a significant influence on a brand, particularly when it comes to Gen Z and Millennial demographics. At the same time, politicians can lend an air of credibility and provide valuable insights into the regulatory future of a market. These attributes have made them invaluable to cannabis companies that […]
Halo Labs: Building a Cannabis Concentrates Empire
Cannabis concentrates are projected to reach $8 billion by 2022, according to BDS Analytics and Arcview Market Research, making it the fastest growing of the three major segments of the legal cannabis market (flower, concentrates, and edibles). In particular, vaporizers sales soared from less than $100 million in 2014 to more than half of total […]
MediPharm Labs Executing on International Cannabis Extracts Strategy
Canadian companies have a bit of a head start on those from other countries where the legal cannabis framework is not as comprehensive or advanced. In many ways, countries around the globe look to Canada as a model. In fact, Australia has basically adopted Canadian medical regulations and is a few years behind Canada in […]
Halo Expands Branded Products & Launches Hemp CBD Products
The cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, driven by the legalization of recreational cannabis across a growing number of states and countries. While there are many different opportunities in the space, there are only a handful of companies that have proven their ability to generate significant […]
Israel Decriminalizes Adult Use Cannabis in Another Step Toward Legalization
Israel decriminalized adult use cannabis on April 1 — just days before the Jewish state’s April 9 election. The new law makes it legal for Israeli citizens to possess homegrown marijuana plants, while carrying small amounts of cannabis in public will only result in a fine rather than an arrest. The move follows similar legislation […]
Harvest One Ensures Cannabis Supply with Greenbelt Acquisition
Vertical integration has become kind of a buzzword in the cannabis industry over the last few years. Many companies claim it as a goal, with the intent of controlling the whole supply chain for their products from seed-to-sale. Getting to that level of control can prove difficult, however, as the resources, equipment, and expertise required […]
Halo Labs: Building A Cannabis Concentrate & Oil Empire
Concentrates are the fastest growing segment of the cannabis industry, according to Arcview Market Research, with sales growing nearly 50 percent to about $3 billion last year in the US. As consumers seek out discreet and healthier consumption methods, the market intelligence firm predicts that US concentrate sales will reach $8.4 billion by 2022 and […]
American Cannabis Market Fueled By Positive Legislation
Cannabis may be illegal on a federal level across the United States, but that hasn’t stopped a multi-billion dollar industry from emerging on the state level. While some investors have avoided the country’s cannabis market due to the federal risk, new cannabis legislation in the House and Senate could dramatically reshape the industry’s risk profile. […]
The time for promise and a good story is over in the cannabis industry. Potential production has been replaced with actual sales, and companies are distinguishing themselves with real revenue growth and clear paths to profitability. There is certainly much to be written in the ever-evolving story of cannabis, but the best companies are executing […]
FSD Pharma Appoints Charles Pollack Jr. MD, FACEP as Chairman of the Scientific Advisory Board
TORONTO FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), announced today the appointment of Charles V. Pollack, Jr., M.A., M.D., FACEP, FAAEM, FAHA, FACC, FESC, FCPP, as Chairman of its Scientific Advisory Board (“SAB”). In this capacity Dr. Pollack will serve as a strategic guide and resource to the Company […]
ISRACANN Biosciences: Invest in Israel’s First Cannabis Pure-Play Public Offering
North America may be capturing most of the headlines when it comes to the cannabis industry, but other global cannabis frontier markets could offer greater growth potential. Israel is already well-known as the cannabis research capital of the world. Similarly, it also has a nascent domestic cannabis industry with one of the highest ratios of […]
Harvest One Executing on Brands and Distribution Strategy
The nature of the compelling stories in the cannabis industry has changed over the last few years. Remember when a late-stage ACMPR applicant was all the rage? Then it was production expansion and funded capacity. Now, all of that potential is turning to the reality of any market – who can sell product and generate […]
Aleafia Health & Emblem Merger Creates a New Cannabis Leader
Aleafia Health Inc. (TSX: ALEF) (OTCQB: ALEAF) (FRA: ARAH) recently announced the completion of its merger with Emblem Corp. Under the terms of the agreement, Aleafia Health acquired all of Emblem’s common shares and formed a new wholly-owned subsidiary that will keep the name Emblem name. The completion of the merger marks a key milestone […]
‘SXSW®’ Held by Cannabis Now Will Take Place March 12-13th, 2019 LOS ANGELES, March 7, 2019 /PRNewswire/ — Weekend Unlimited USA Inc. (“Weekend” or the “Company”) (CSE: POT) (FSE: 0OS1) (OTCQB: WKULF) announces that recent acquisition, VBC Brands, under the CHAMP Energy brand, will sponsor “The South by Southwest® (SXSW®) conference & festival,” taking place on […]
Heart failure (HF) affects more than 6 million adults in Canada and the United States and is a leading cause of hospitalization, with costs exceeding $30 billion each year in the US alone. People with HF suffer from shortness of breath, rapid heart rate, edema, reduced exercise capacity, often struggle with simple daily activities, and […]
BNN Bloomberg Identifies Indiva as Rapidly Growing in the Cannabis Sector
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./ LONDON, ON, Feb. 15, 2019 /CNW/ – Indiva Limited (the “Company” or “Indiva“) (TSX:NDVA) (US:NDVAF): On BNN Bloomberg this Saturday February 16 and Sunday February 17, 2019 – BTV- Business Television visits five distinctive companies in the rapidly growing cannabis sector. […]
3 Sixty Risk Solutions Commences Trading on the Frankfurt Stock Exchange
/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ ALMONTE, ON, Feb. 15, 2019 /CNW/ – 3 Sixty Risk Solutions Ltd. (“3 Sixty” or the “Company“) (CSE: SAFE) (FSE: 62P2), which operates through its wholly-owned subsidiary, 3 Sixty Secure Corp., is pleased to announce that it has commenced trading […]
Indiva announces initial supply agreement with the Ontario Cannabis Store
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./ LONDON, ON, Feb. 8, 2019 /CNW/ – Indiva Limited (the “Company” or “Indiva“) (TSX:NDVA) (US:NDVAF) is excited to announce its first supply agreement with the Ontario Cannabis Retail Corporation (“OCRC”), doing business as the Ontario Cannabis Store (“OCS”). This initial partnership […]
MedMen Completes Previously Announced Acquisition of Illinois Dispensary
MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) (FSE: A2JM6N) is pleased to announce that it has closed its previously announced acquisition (the “Acquisition”) of Seven Point, a licensed medical cannabis dispensary located in the historic Chicago suburb of Oak Park, Illinois. Pursuant to the Acquisition, the Company paid a combination of […]
MONTREAL, Feb. 07, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the new launch of the Push and Pull System™, an innovation in delivering a comprehensive solution for skin care, designed specifically for today’s active women. THE FIRST EVER The Push […]
Aleafia Health Helps Patients & Investors with Revenue Generating Research
Medical cannabis research is only starting to scratch the surface of how cannabinoids could play a role in areas traditionally dominated by prescription pharmaceuticals. Given the massive size of the pharmaceutical industry, these insights could translate to significant value for first-movers in large indications. The problem is that there’s limited data given the newness and […]
FSD Pharma Looks to Grow Cannabinoids in Algae
Algae-based technologies have become a popular source of everything from alternative fuel to nutritional supplements. Like bacteria, algae can also be used to produce a wide range of bioactive recombinant proteins that can be leveraged to create a wide range of other molecules—including high-value therapeutic molecules. Cutting-edge researchers are looking at ways to create synthetic […]
Aleafia Health to Accelerate Research Division with Appointment of Product Data Science Fellow
Research Revenue Totalled $0.6 Million in Q3 2018 Product Data Science Fellow to Lead Evidence-Based Product Research via Proprietary, 10M Point Patient Dataset TORONTO, Feb. 04, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”), has appointed Dr. Graham Merry, as the Company’s first Product Data […]
Halo Labs Provides Operational Update & Announces Closing of Promissory Note
TORONTO–(BUSINESS WIRE)– Halo Labs Inc. (“Halo” or the “Company“) (NEO:HALO, OTC:AGEEF) is pleased to provide an operational update given the recent developments at the Company in the past few months and announces the closing of a promissory note financing. Halo’s CEO, Kiran Sidhu, stated: “As we start the new year off, I would like to […]
How Cannabinoids Could Replace Opioids
Chronic pain affects more than 100 million Americans at an annual cost of $600 billion, according to the Institute of Medicine. The National Institute of Drug Abuse estimates that roughly 21 to 29 percent of chronic pain patients misuse opioid drugs and 8 to 12 percent go on to develop an opioid addiction. More than […]
48North Provides Update on its 100-acre Outdoor Farm Application
TORONTO, Jan. 24, 2019 /CNW/ – 48North Cannabis Corp. (“48North” or the “Company”) (TSXV:NRTH) is pleased to announce that it has submitted its site evidence package to Health Canada in connection with its license application, submitted in October 2018, for the Company’s 100-acre outdoor farm in Brant County, Ontario. The farm site evidence package is […]
Pascal Biosciences Commences Cannabinoid Testing of Human Volunteers and Patients
VANCOUVER, British Columbia, and SEATTLE, Jan. 24, 2019 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the testing of cannabinoids in human subjects for its immune stimulatory program in cancer. Furthermore, the Company has filed an international patent application to protect this work for […]
YIELD GROWTH Announces listing in Frankfurt (YG3) and Trading Symbol on OTC Markets (OTC:BOSQF)
VANCOUVER, British Columbia, Jan. 24, 2019 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS) (BOSQF) (Frankfurt:YG3) is pleased to announce that Yield Growth’s common shares have been listed on the Frankfurt Stock Exchange under the trading symbol “YG3”. Yield Growth is also now quoted on OTC Markets under the symbol “BOSQF”. The company’s common shares […]
Producing Supreme Cannabis At Scale
Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte analysts, driven by the legalization of recreational cannabis last year. While many licensed producers are ramping up capacity, investors may want to shift their focus to the handful of companies that are doubling down on product quality. These companies […]
CFN Media recently sat down with Aleafia Health Inc. (TSX-V: ALEF) (OTCQX: ALEAF) (FRA: ARAH) CEO Geoffrey Benic to discuss the company’s acquisition of Emblem Corp. (TSX-V: EMC) (OTCQX: EMMBF) creating Canada’s largest cannabis clinic network along with 138,000 kilograms per year of planned annual cultivation capacity—making it an overnight leader in the medical side […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Technical420 is the premier provider of research and analysis on cannabis stocks. We provide investors with sponsored and non-sponsored information on the volatile and emerging cannabis industry. “Our research is our passion!” Your profit is our reward!
MichiCann Medical Inc. owns or controls 11 medical cannabis dispensaries in Michigan and is in the final stages to acquire another 11 shops, as well as three indoor cultivation facilities in the state.
Biome Grow (CSE: BIO) wholly owns Highland Grow, an Authorized Licensed Producer in Nova Scotia under the ACMPR, P-209 Inc., a company incorporated under the laws of the Province of Ontario and in the late stages of applying for a license under the ACMPR.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
